These results suggest that TNF-α blockade may represent a therapeutic strategy offering more precise and durable control of the hyperinflammatory cytokine signature of COVID-19, compared to the broad-spectrum anti-inflammatory effects of steroid therapy [129]. The gene discussed is TNF; the disease is COVID-19.